254 related articles for article (PubMed ID: 8651245)
1. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
[TBL] [Abstract][Full Text] [Related]
2. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
[TBL] [Abstract][Full Text] [Related]
3. Incipient and overt diabetic nephropathy in African Americans with NIDDM.
Dasmahapatra A; Bale A; Raghuwanshi MP; Reddi A; Byrne W; Suarez S; Nash F; Varagiannis E; Skurnick JH
Diabetes Care; 1994 Apr; 17(4):297-304. PubMed ID: 8026285
[TBL] [Abstract][Full Text] [Related]
4. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
Lehmann R; Spinas GA
Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
7. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
8. Albuminuria in nondiabetic relatives of IDDM patients with and without diabetic nephropathy.
Fagerudd JA; Pettersson-Fernholm KJ; Riska MK; Grönhagen-Riska C; Groop PH
Kidney Int; 2000 Sep; 58(3):959-65. PubMed ID: 10972659
[TBL] [Abstract][Full Text] [Related]
9. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
[TBL] [Abstract][Full Text] [Related]
10. LDL subclasses in IDDM patients: relation to diabetic nephropathy.
Lahdenperä S; Groop PH; Tilly-Kiesi M; Kuusi T; Elliott TG; Viberti GC; Taskinen MR
Diabetologia; 1994 Jul; 37(7):681-8. PubMed ID: 7958539
[TBL] [Abstract][Full Text] [Related]
11. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes.
Fried LF; Forrest KY; Ellis D; Chang Y; Silvers N; Orchard TJ
J Diabetes Complications; 2001; 15(3):113-9. PubMed ID: 11358679
[TBL] [Abstract][Full Text] [Related]
12. Progressive decline in renal function in diabetic patients with and without albuminuria.
Tsalamandris C; Allen TJ; Gilbert RE; Sinha A; Panagiotopoulos S; Cooper ME; Jerums G
Diabetes; 1994 May; 43(5):649-55. PubMed ID: 8168641
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor and development of diabetic nephropathy in IDDM.
Stehouwer CD; Stroes ES; Hackeng WH; Mulder PG; Den Ottolander GJ
Diabetes; 1991 Aug; 40(8):971-6. PubMed ID: 1907250
[TBL] [Abstract][Full Text] [Related]
14. No evidence of an exaggerated albuminuric response to physical exercise in non-diabetic siblings of type 1 diabetic patients with diabetic nephropathy.
Fagerudd JA; Riska MK; Pettersson-Fernholm KJ; Groop PH
Scand J Clin Lab Invest; 2000 Oct; 60(6):449-55. PubMed ID: 11129060
[TBL] [Abstract][Full Text] [Related]
15. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
16. The 10-year incidence of renal insufficiency in people with type 1 diabetes.
Klein R; Klein BE; Moss SE; Cruickshanks KJ; Brazy PC
Diabetes Care; 1999 May; 22(5):743-51. PubMed ID: 10332675
[TBL] [Abstract][Full Text] [Related]
17. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
[TBL] [Abstract][Full Text] [Related]
18. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
Chiarelli F; Verrotti A; Mohn A; Morgese G
Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation in glomerular charge selectivity, urinary albumin excretion and blood pressure in insulin-dependent diabetic patients.
Hansen PM; Goddijn PP; Kofoed-Enevoldsen A; van Tol KM; Bilo HJ; Deckert T
Kidney Int; 1995 Nov; 48(5):1559-62. PubMed ID: 8544414
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.
Chiarelli F; Pomilio M; Mohn A; Tumini S; Vanelli M; Morgese G; Spagnoli A; Verrotti A
J Pediatr; 2000 Sep; 137(3):386-92. PubMed ID: 10969265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
